Anuh Pharma Limited share price
NSE: ANUHPHR · ISIN INE489G01022
Key numbers
- Market cap
- ₹ 906 Cr
- Current price
- ₹ 90.42
- 52-week high / low
- ₹ 100 / 67
- Stock P/E
- 25.4
- Book value
- ₹ 35.1
- Dividend yield
- 1.66%
- ROCE
- 15.9%
- ROE
- 12.1%
- Debt to equity
- 0.00
- Sales growth (3 yrs)
- 13.5%
- Profit growth (3 yrs)
- 4.3%
- 1-year return
- 4.5%
About Anuh Pharma Limited
Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-malarial, anti-hypertension, expectorant, anti-diabetics, anti-bacterial, anti-gout, anti asthmatics, quinolones, anti biotic, anti platelet, anti-histamines, and intermediates; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, and anti-mitotic. The company also develops products, such as anticoagulant, antagonist, anti convulsants, anty-ulcerative, anty-ulcerative, anticholinergics, anti-anemic, antidepressant, and mucolytic agents. It also exports its products. Anuh Pharma Limited was incorporated in 1960 and is headquartered in Mumbai, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 186 | 186 | 197 | 202 | 194 |
| Operating profit | 10 | 12 | 17 | 20 | 16 |
| Net profit | 8 | 8 | 13 | 12 | 11 |
| EPS (₹) | 1.66 | 0.76 | 1.34 | 1.17 | 1.14 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.